Six months is a realistic horizon for the kind of change that turns heads, and the scale rarely moves in a tidy straight line
[14] [15] Regular medication reviews typically every 36 months initially, then annuallyallow you and your healthcare team to reassess whether continuing GLP-1 therapy remains the best approach for your individual circumstances, based on both benefits and risks
The clinical relevance of the increased exposure of furosemide and rosuvastatin was not assessed in this trial
One documented case involved $1,161 in unauthorized charges after a cancellation request
Do not stop any current treatment without medical consultation
Packages typically include an initial consultation, medication guidance, ongoing clinical support, and scheduled follow-ups to track progress and adjust the plan